These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25283138)

  • 41. Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.
    Tschaidse L; Reisch N; Arlt W; Brac de la Perriere A; Linden Hirschberg A; Juul A; Mallappa A; Merke DP; Newell-Price JDC; Perry CG; Prete A; Rees DA; Stikkelbroeck NMML; Touraine PA; Coope H; Porter J; Ross RJM; Quinkler M
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36654495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical analysis of 78 patients with nonclassical 21-hydroxylase deficiency.
    Liu E; Luo H; Zhou K; Zhang Y
    Arch Gynecol Obstet; 2023 Sep; 308(3):871-882. PubMed ID: 36773044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
    Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys.
    Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1162-9. PubMed ID: 11889181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.
    Newfield RS; Sarafoglou K; Fechner PY; Nokoff NJ; Auchus RJ; Vogiatzi MG; Jeha GS; Giri N; Roberts E; Sturgeon J; Chan JL; Farber RH
    J Clin Endocrinol Metab; 2023 Oct; 108(11):2871-2878. PubMed ID: 37216921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid monitoring assay of congenital adrenal hyperplasia with microbore high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.
    Lai CC; Tsai CH; Tsai FJ; Lee CC; Lin WD
    Rapid Commun Mass Spectrom; 2001; 15(22):2145-51. PubMed ID: 11746879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physiological changes of adrenal androgens in childhood.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    J Formos Med Assoc; 2004 Dec; 103(12):921-4. PubMed ID: 15624041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.
    Sarafoglou K; Kim MS; Lodish M; Felner EI; Martinerie L; Nokoff NJ; Clemente M; Fechner PY; Vogiatzi MG; Speiser PW; Auchus RJ; Rosales GBG; Roberts E; Jeha GS; Farber RH; Chan JL;
    N Engl J Med; 2024 Aug; 391(6):493-503. PubMed ID: 38828945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the diurnal variations of 17-hydroxyprogesterone in saliva by enzyme immunoassay in patients with congenital adrenal hyperplasia.
    Hoepffner W; Hubl W
    Exp Clin Endocrinol; 1986 Jul; 87(2):189-94. PubMed ID: 3530788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diurnal 11-ketotestosterone and 17-hydroxyprogesterone saliva profiles in paediatric classical congenital adrenal hyperplasia.
    Dubinski I; Bechtold-Dalla Pozza S; Bidlingmaier M; Hawley J; Keevil B; Kunz S; Nowotny HF; Reisch N; Schiergens K; Tschaidse L; Schmidt H
    J Pediatr Endocrinol Metab; 2024 May; 37(5):419-424. PubMed ID: 38557593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia.
    Solish SB; Goldsmith MA; Voutilainen R; Miller WL
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1148-52. PubMed ID: 2555382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Girls with virilisation in childhood: a diagnostic protocol for investigation.
    Street ME; Weber A; Camacho-Hübner C; Perry LA; Brain CE; Cotterill AM; Savage MO
    J Clin Pathol; 1997 May; 50(5):379-83. PubMed ID: 9215119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J; Lisá L; Dvorák P; Hampl R; Stárka L
    Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
    van der Kamp HJ; Oudshoorn CG; Elvers BH; van Baarle M; Otten BJ; Wit JM; Verkerk PH
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3904-7. PubMed ID: 15797960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
    Granoff AB; Chasalow FI; Blethen SL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormonal disturbances due to severe and mild forms of congenital adrenal hyperplasia are already detectable in neonatal life.
    Faurschou S; Mouritsen A; Johannsen TH; Hougaard DM; Cohen A; Duno M; Juul A; Main KM
    Acta Paediatr; 2015 Feb; 104(2):e57-62. PubMed ID: 25346389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal screening for congenital adrenal hyperplasia.
    Barra CB; Silva IN; Pezzuti IL; Januário JN
    Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.